Muva nje, jymed Technology Co, Ltd. Kumemezele ukuthi i-Leuprorelin acetate, ekhiqizwa yiHubei Jx Jx Bio-Pharmaceutical Co, Ltd, idlule ngempumelelo ukuhlolwa kwezidakamizwa.
Ukubuka konke okuqala kwezidakamizwa
I-Leuprorelin Acetate iyindlela yokujova esetshenziselwa ukwelapha izifo ezincike kuma-hormone-ancike, ngefomula lika-c59h84N16O12 • xc2h4o2. Kuyi-agonist ye-hormone-ekhulula i-gonadotropin (GNRHA) esebenza ngokuvimbela uhlelo lwePutuitary-Gonadal. Ekuqaleni wakhulelwa yi-Abbvie neTakeda Pharmaceutical, lesi sidakamizwa sithengiswa ngaphansi kwamagama ahlukahlukene ahlukahlukene emazweni ahlukahlukene. E-United States, kuthengiswa ngaphansi kwegama lomkhiqizo uLupron Depot, ngenkathi eseChina, kuthengiswa njenge-Yina Tong.
Inqubo ecacile nezindima ezichazwe kahle
Kusukela ngo-2019 kuya ku-2022, ucwaningo lwezemithi nentuthuko kwaqedwa, kulandelwa ukubhaliswa kwe-API ngoMashi 2024, lapho kwamukelwa isaziso sokwamukelwa. Ukuhlolwa kokubhaliswa kwezidakamizwa kwaphasiswa ngo-Agasti 2024. I-Jment Technology Co, Ltd ibibhekele ukuthuthukiswa kwenqubo, ukuthuthukiswa kwendlela yokuhlaziya, izifundo zokungcola, ukuqinisekiswa kwesakhiwo, kanye nokuqinisekiswa kwendlela. I-Hubei Jx Bio-Pharmaceutical Co, Ltd. Bekuphethe ukukhiqizwa kokuqinisekiswa kwenqubo, ukuqinisekiswa kwendlela yokuqinisekisa, kanye nokuqina kwezinyoka ze-API.
Ukunwebeka Imakethe Nesidingo Esikhulayo
Izehlakalo ezikhulayo ze-Prostate Cancer kanye ne-Uterine Fibroids zishayela isidingo esandayo se-Leuprorelin Acetate. Imakethe yaseNyakatho Melika ibusa emakethe ye-leuprorelin acetate, ngezindleko ezikhulayo zezempilo kanye nokwamukelwa okuphezulu kobuchwepheshe obusha abangabashayeli bokukhula okuyisisekelo. Ngasikhathi sinye, imakethe yase-Asia, ikakhulukazi iChina, futhi ikhombisa isidingo esinamandla se-Leuprorelin actate. Ngenxa yokusebenza kwayo, ukufunwa komhlaba wonke kwalesi sidakamizwa kukhuphuke, ngosayizi wemakethe kulindeleke ukuthi afinyelele ezigidini ezingama-3 9466.1 ngo-2031, ekhombisa isilinganiso esikhulayo sonyaka (i-CAGR) ka-2021 kuya ku-2031.
Mayelana noJymed
I-Shenzhen jymed Technology Co, Ltd. (Laqishefethi okukhulunywa ngayo njengoba uJymed) yasungulwa ngo-2009, enakekela ocwaningweni, ekuthuthukisweni, ekukhiqizeni nasekuthengisweni kwemikhiqizo ehlobene ne-pepttide. Ngama-One Research Center kanye nezisekelo ezintathu ezinkulu zokukhiqiza, i-jymed ingenye yezisebenzi ezinkulu kakhulu zamakhemikhali enzelwe amakhemikhali we-peptide apes in China. Iqembu le-Core R & D liqhosha iminyaka engaphezu kwengu-20 yesipiliyoni embonini ye-pepttide futhi selidlule ngempumelelo ukuhlolwa kwe-FDA kabili. Uhlelo oluphelele lwe-Pepment oluphelele nolusebenzayo lwe-Peptide lwe-Weeptide lunikeza amakhasimende uhla oluphelele lwezinsizakalo, kufaka phakathi ukuthuthukiswa kwama-peptides zokwelapha, ama-peptides wezilwane, ama-antimicrobial ama-peptides, kanye nokubhalisa kanye nokusekelwa kokubhaliswa.
Imisebenzi Eyinhloko Yebhizinisi
Ukubhaliswa kwe-1.domatoristic kanye namazwe aphesheya kwama-peptide apis
Ama-ceptides angama-2.vetetic kanye nama-cosmetic
3.Custom Peptides kanye ne-CRO, CMO, OEM Services
Izidakamizwa ze-4.PDC (i-peptide-radionuclide, i-pottide-molecule-molecule encane, i-peptide-protein, i-peptide-rna)
Ngaphezu kwe-leuprorelin acetate, i-jymed ihale imidwebo yokubhalisa nge-FDA ne-CDE ngeminye imikhiqizo eminingana ye-API, kufaka phakathi izidakamizwa ezithandwayo ze-API ezinamanje, izidakamizwa zase-GLP-1ra ezithandwa njengamanje njenge-semarlutide, i-liraglutide ne-tirezeptide. Amakhasimende esikhathi esizayo asebenzisa imikhiqizo kaJymed's azokwazi ukubheka ngqo inombolo yokubhaliswa kwe-CDE noma inombolo yefayela le-DMF lapho uhambisa izinhlelo zokubhalisa ku-FDA noma i-CDE. Lokhu kuzonciphisa kakhulu isikhathi esidingekayo sokulungiselela amadokhumenti okusebenzisa, kanye nesikhathi sokuhlola kanye nezindleko zokubuyekezwa komkhiqizo.
Xhumana nathi
I-Shenzhen jymed Technology Co, Ltd.
Ikheli:Izitezi ze-8 & 9th, zokwakha 1, iShenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subribistre, Pingzhen
Ucingo:+86 755-266121112
Iwebhusayithi:http://www.jymedtech.com/
Isikhathi sePosi: Aug-29-2024
